Magnesium in prevention and therapy

Nutrients

Volumn 7, Issue 9, 2015, Pages 8199-8226

  Gröber, Uwe ^a   Schmidt, Joachim ^a   Kisters, Klaus ^a,b  

^a Academy of Micronutrient Medicine   (Germany)

^b ST ANNA HOSPITAL   (Germany)

Author keywords

ADHD; Alzheimer s disease; Asthma; Cardiovascular disease; Diabetes mellitus; Hypomagnesemia; Magnesium

Indexed keywords

MAGNESIUM;

ALZHEIMER DISEASE; ASTHMA; ATTENTION DEFICIT DISORDER; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; DRUG INDUCED DISEASE; ECLAMPSIA AND PREECLAMPSIA; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; INSULIN RESISTANCE; ION TRANSPORT; ISCHEMIC HEART DISEASE; MAGNESIUM INTAKE; MAGNESIUM METABOLISM; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MIGRAINE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW (TOPIC); ADVERSE EFFECTS; ANIMAL; DIETARY REFERENCE INTAKE; DIETARY SUPPLEMENT; HOMEOSTASIS; MAGNESIUM DEFICIENCY; METABOLISM; NUTRITIONAL STATUS; RISK FACTOR; TREATMENT OUTCOME;

ANIMALS; DIETARY SUPPLEMENTS; HOMEOSTASIS; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY; NUTRITIONAL STATUS; RECOMMENDED DIETARY ALLOWANCES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84942474531     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7095388     Document Type: Review

References (149)

1. Cotton, F.A.; Wilkinson, G. Anorganische Chemie; Chemie GmbH: Weilheim, Germany, 1967.
2. Weast, R.C. Handbook of Chemistry and Physics; CRC Press: Boca Raton, FL, USA, 1987.
3. Hollemann, A.F.; Wiberg, E. Lehrbuch der Anorganischen Chemie; De Gruyter: Berlin, Germany, 1964.
4. Bodaker, I.; Sharon, I.; Suzuki, M.; Feingersch, R.; Shmoish, M.; Andreishcheva, E.; Sogin, M.L.; Rosenberg, M.; Maguiere, M.E.; Belkin, S.; et al. Comparative community genomics in the Dead Sea: An increasingly extreme environment. ISME J. 2010, 4, 399-407. [CrossRef] [PubMed]
5. Song, Y.; Ridker, P.M.; Manson, J.E.; Cook, N.R.; Buring, J.E.; Liu, S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. Women. Diabetes Care 2005, 28, 1438-1444. [CrossRef] [PubMed]
6. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes; Food and Nutrition Board; Institute of Medicine (IOM). Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride; National Academies Press: Washington, DC, USA, 1997.
7. Gröber, U. Magnesium. In Micronutrients: Metabolic Tuning-Prevention-Therapy, 1st ed.; Gröber, U., Ed.; MedPharm Scientific Publishers: Stuttgart, Germany, 2009; pp. 159-166.
8. Rude, R.K. Magnesium. In Encyclopedia of Dietary Supplements, 2nd ed.; Coates, P.M., Betz, J.M., Eds.; Informa Healthcare: New York, NY, USA, 2010; pp. 527-537.
9. Rude, R.K. Magnesium. In Modern Nutrition in Health and Disease, 11th ed.; Ross, A.C., Caballero, B., Cousins, R.J., Tucker, K.L., Ziegler, T.R., Eds.; Lippincott Williams & Wilkins: Baltimore, MA, USA, 2012; pp. 159-175.
10. Swaminathan, R. Magnesium metabolism and its disorders. Clin. Biochem. Rev. 2003, 24, 47-66. [PubMed]
11. Castiglioni, S.; Cazzaniga, A.; Albisetti, W.; Maier, J.A. Magnesium and osteoporosis: Current state of knowledge and future research directions. Nutrients 2013, 5, 3022-3033. [CrossRef] [PubMed]
12. Classen, H.G.; Nowitzki, S. The clinical importance of magnesium. The indications for supplementation and therapy. Fortschr. Med. 1990, 10, 198-200.
13. Kisters, K. Störungen des Magnesiumhaushaltes. Internist 1998, 39, 815-819. [CrossRef] [PubMed]
14. Seelig, M.S. Magnesium requirements in human nutrition. J. Med. Soc. N. J. 1982, 79, 849-850. [PubMed]
15. Jahnen-Dechent, J.; Ketteler, M. Magnesium basics. Clin. Kidney J. 2012, 5, i3-i14. [CrossRef] [PubMed]
16. Ismail, Y.; Ismail, A.A. The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for "normal" results. Clin. Chem. Lab. Med. 2010, 48, 323-327. [CrossRef] [PubMed]
17. Von Ehrlich, E.; Barbagallo, M.; Classen, H.G.; Guerrero-Romero, F.; Morren, F.C.; Rodriguez-Moran, M.; Vierling, W.; Vormann, J; Kisters, K. The significance of magnesium in insulin resistance, metabolic syndrome, and diabetes-Recommendations of the Association of Magnesium Research e.V. Diabetol. Stoffwechs. 2014, 9, 96-100.
18. Vormann, J. Update: Magnesium und Diabetes. OM-Z. Orthomol. Med. 2014, 1, 6-8.
19. Švagždienė, M.; Širvinskas, E.; Baranauskienė, D.; Adukauskienė, D. Correlation of magnesium deficiency with C-reactive protein in elective cardiac surgery with cardiopulmonary bypass for ischemic heart disease. Medicina (Kaunas) 2015, 51, 100-106. [CrossRef] [PubMed]
20. Moshfegh, A.; Goldman, J.; Ahuja, J.; Rhodes, D.; LaComb, R. What We Eat in America, NHANES 2005-2006: Usual Nutrient Intakes from Food and Water Compared to 1997 Dietary Reference Intakes for Vitamin D, Calcium, Phosphorus, and Magnesium; U.S. Department of Agriculture, Agricultural Research Service: Washington, DC, USA, 2009.
21. Nationale Verzehrsstudie II. Available online: http://www.was-esse-ich.de/uploads/media/NVSII_Abschlussbericht_Teil_2.pdf (accessed on 13 June 2015).
22. Shah, N.C.; Shah, J.G.; Li, Z.; Jiang, X.C.; Altura, B.T.; Altura, B.M. Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging. Int. J. Clin. Exp. Med. 2014, 7, 497-514. [PubMed]
23. Ma, J.; Folsom, A.R.; Melnick, S.L.; Eckfeldt, J.H.; Sharrett, A.R.; Nabulsi, A.A.; Hutchinson, R.G.; Metcalf, P.A. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Communities Study. J. Clin. Epidemiol. 1995, 48, 927-940. [CrossRef]
24. Altura, B.M. Introduction: importance of Mg in physiology and medicine and the need for ion selective electrodes. Scand. J. Clin. Lab. Invest. Suppl. 1994, 217, 5-9. [CrossRef] [PubMed]
25. Marx, A.; Neutra, R.R. Magnesium in drinking water and ischemic heart disease. Epidemiol. Rev. 1997, 19, 258-272. [CrossRef] [PubMed]
26. Magnesium. Available online: http://fnic.nal.usda.gov/food-composition/vitamins-and-minerals/magnesium (accessed on 8 January 2015).
27. Nielsen, F.H. Magnesium, inflammation, and obesity in chronic disease. Nutr Rev. 2010, 68, 333-340. [CrossRef] [PubMed]
28. Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey. Available online: http://www.ars.usda.gov/SP2UserFiles/Place/80400530/pdf/0506/usual_nutrient_intake_vitD_ca_phos_mg_2005-06.pdf (accessed on 8 January 2015).
29. Chiuve, S.E.; Korngold, E.C.; Januzzi, J.L., Jr.; Gantzer, M.L.; Albert, C.M. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am. J. Clin. Nutr. 2011, 93, 253-260. [CrossRef] [PubMed]
30. Larsson, S.C.; Orsini, N.; Wolk, A. Dietary magnesium intake and risk of stroke: A meta-analysis of prospective studies. Am. J. Clin. Nutr. 2012, 95, 362-366. [CrossRef] [PubMed]
31. Durlach, J. Magnesium depletion and pathogenesis of Alzheimer’s disease. Magnes. Res. 1990, 3, 217-218. [PubMed]
32. Rosanoff, A.; Plesset, M.R. Oral magnesium supplements decrease high blood pressure (SBP > 155 mm Hg) in hypertensive subjects on anti-hypertensive medications: A targeted meta-analysis. Magnes. Res. 2013, 26, 93-99. [PubMed]
33. Barbagallo, M.; Belvedere, M.; Dominguez, L.J. Magnesium homeostasis and aging. Magnes. Res. 2009, 22, 235-246. [PubMed]
34. Palmer, B.F.; Clegg, D.J. Electrolyte and Acid-Base Disturbances in Patients with Diabetes Mellitus. N. Engl. J. Med. 2015, 373, 548-559. [PubMed]
35. Graham, L.A.; Caesar, J.J.; Burgen, A.S. Gastrointestinal absorption and excretion of Mg 28 in man. Metabolism 1960, 9, 646-659. [PubMed]
36. Saris, N.E.; Mervaala, E.; Karppanen, H.; Khawaja, J.A.; Lewenstam, A. Magnesium: An update on physiological, clinical and analytical aspects. Clin. Chim. Acta 2000, 294, 1-26. [CrossRef]
37. Jeroen, H.; de Baaij, F.; Joost, G.; Hoenderop, J.; Rene, J.; Bindels, M. Regulation of magnesium balance: Lessons learned from human genetic disease. Clin. Kidney J. 2012, 5, i15-i24.
38. Quamme, G.A. Recent developments in intestinal magnesium absorption. Curr. Opin. Gastroenterol. 2008, 24, 230-235. [CrossRef] [PubMed]
39. Amasheh, S.; Fromm, M.; Günzel, D. Claudins of intestine and nephron-A correlation of molecular tight junction structure and barrier function. Acta. Physiol. (Oxf). 2011, 201, 133-140. [CrossRef] [PubMed]
40. Touyz, R.M. Magnesium in clinical medicine. Front. Biosci. 2004, 9, 1278-1293. [CrossRef] [PubMed]
41. 2+ homeostasis: The balancing act of TRPM6. Curr. Opin. Nephrol. Hypertens. 2014, 23, 361-369. [CrossRef] [PubMed]
42. Tokmak, F.; Kisters, K.; Hausberg, M.; Rump, L.C. Buffer function of the cell membrane for magnesium in chronic kidney disease. Trace Elem. Electrol. 2008, 25, 234-235.
43. Zittermann, A. Magnesium deficit? Overlooked cause of low vitamin D status? BMC Med. 2013, 11, [CrossRef] [PubMed]
44. Den, X.; Song, Y.; Manson, J.E.; Signorello, L.B.; Zhang, S.M.; Shrubsole, M.J.; Ness, R.M.; Seidner, D.L.; Dai, Q. Magnesium, vitamin D status and mortality: Results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III. BMC Med. 2013, 11
45. 2+ content and estrogens. J. Am. Soc. Nephrol. 2006, 17, 1035-1043. [CrossRef] [PubMed]
46. Anast, C.S.; Winnacker, J.L.; Forte, L.R.; Burns, T.W. Impaired release of parathyroid hormone in magnesium deficiency. J. Clin. Endocrinol. Metab. 1976, 42, 707-717. [CrossRef] [PubMed]
47. Zofková, I.; Kancheva, R.L. The relationship between magnesium and calciotrophic hormones. Magnes. Res. 1995, 8, 77-84. [PubMed]
48. Tibbetts, D.M.; Aub, J.C. Magnesium metabolism in health and disease. III. In exophthalmic goiter, basophilic adenoma, Addison’s disease and steatorrhea. J. Clin. Investig. 1937, 16, 511-514.
49. Gao, X.; Peng, L.; Adhikari, C.M.; Lin, J.; Zuo, Z. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. J. Card. Fail. 2007, 13, 170-177. [CrossRef] [PubMed]
50. Gibson, R.S. Principles of Nutritional Assessment, 2nd ed.; Oxford University Press: New York, NY, USA, 2005.
51. Witkowski, M.; Hubert, J.; Mazur, A. Methods of assessment of magnesium status in humans: A systematic review. Magnes. Res. 2011, 24, 163-180. [PubMed]
52. Geiger, H.; Wanner, C. Magnesium in disease. Clin. Kidney J. 2012, 5, i25-i38. [CrossRef] [PubMed]
53. Elin, R.J. Assessment of magnesium status for diagnosis and therapy. Magnes. Res. 2010, 23, S194-S198. [PubMed]
54. Lowenstein, F.W.; Stanton, M.F. Serum magnesium levels in the United States, 1971-1974. J. Am. Coll. Nutr. 1986, 5, 399-414. [CrossRef] [PubMed]
55. Liebscher, D.H.; Liebscher, D.E. About the misdiagnosis of magnesium deficiency. J. Am. Coll. Nutr. 2004, 23, 730S-731S. [CrossRef] [PubMed]
56. Everett, C.J.; King, D.E. Serum magnesium and the development of diabetes. Nutrition 2006, 22, [CrossRef] [PubMed]
57. Pham, P.C.; Pham, P.M.; Pham, P.A.; Pham, S.V.; Pham, H.V.; Miller, J.M.; Yanagawa, N.; Pham, P.T. Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type. Clin. Nephrol. 2005, 63, 429-436. [CrossRef] [PubMed]
58. Pham, P.C.; Pham, P.M.; Pham, S.V.; Miller, J.M.; Pham, P.T. Hypomagnesemia in patients with type 2 diabetes. Clin. J. Am. Soc. Nephrol. 2007, 2, 366-373. [CrossRef] [PubMed]
59. Vierling, W.; Liebscher, D.H.; Micke, O.; von Ehrlich, B.; Kisters, K. Magnesium deficiency and therapy in cardiac arrhythmias: Recommendations of the German Society for Magnesium Research. Dtsch. Med. Wochenschr. 2013, 138, 1165-1171. [PubMed]
60. Chernow, B.; Bamberger, S.; Stoiko, M.; Vadnais, M.; Mills, S.; Hoellerich, V.; Warshaw, A.L. Hypomagnesemia in patients in postoperative intensive care. Chest 1989, 95, 391-397. [CrossRef] [PubMed]
61. Whang, R.; Ryder, K.W. Frequency of hypomagnesemia and hypermagnesemia. Requested vs. routine. JAMA 1990, 263, 3063-3064. [CrossRef] [PubMed]
62. Spätling, L.; Classen, H.G.; Külpmann, W.R.; Manz, F.; Rob, P.M.; Schimatschek, H.F.; Vierling, W.; Vormann, J.; Weigert, A.; Wink, K. Diagnosing magnesium deficiency. Current recommendations of the Society for Magnesium Research. Fortschr. Med. Orig. 2000, 118, 49-53. [PubMed]
63. Gröber, U. Interactions between drugs and micronutrients. Med. Monatsschr. Pharm. 2006, 29, 26-35. [CrossRef] [PubMed]
64. Gröber, U. Antihypertensives and magnesium-Update 2007. Trace. Elem. Electrolyt. 2009, 26, 15-16. [CrossRef]
65. Classen, H.G.; Gröber, U.; Kisters, K. Drug-induced magnesium deficiency. Med. Monatsschr. Pharm. 2012, 35, 274-280. [PubMed]
66. Massy, Z.A.; Drüeke, T.B. Magnesium and cardiovascular complications of chronic kidney disease. Nat. Rev. Nephrol. 2015. [CrossRef] [PubMed]
67. Guerrero-Romero, F.; Simental-Mendía, L.E.; Hernández-Ronquillo, G.; Rodriguez-Morán, M. Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: A double-blind placebo-controlled randomized trial. Diabetes Metab. 2015, 41, 202-207. [CrossRef] [PubMed]
68. Kisters, K.; Gröber, U. Lowered magnesium in hypertension. Hypertension 2013, 62, e19. [CrossRef] [PubMed]
69. Ishimura, E.; Okuno, S.; Yamakawa, T.; Inaba, M.; Nishizawa, Y. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes. Res. 2007, 20, 237-244. [PubMed]
70. Altura, B.M.; Altura, B.T. Magnesium and cardiovascular biology: An important link between cardiovascular risk factors and atherogenesis. Cell. Mol. Biol. Res. 1995, 41, 347-359. [PubMed]
71. Djurhuus, M.S.; Skøtt, P.; Hother-Nielson, O.; Klitgaard, N.A.; Beck-Nielsen, H. Insulin increases renal magnesium excretion: A possible cause of magnesium depletion in hyperinsulinaemic states. Diabet. Med. 1995, 12, 664-669. [CrossRef] [PubMed]
72. Ramadass, S.; Basu, S.; Srinivasan, A.R. Serum magnesium levels as an indicator of status of Diabetes Mellitus type Diabetes Metab. Syndr. 2015, 9, 42-45. [CrossRef] [PubMed]
73. Perazella, M.A. Proton pump inhibitors and hypomagnesemia: A rare but serious complication. Kidney Int. 2013, 83, 553-556. [CrossRef] [PubMed]
74. Barragán-Rodríguez, L.; Rodríguez-Morán, M.; Guerrero-Romero, F. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: A randomized, equivalent trial. Magnes. Res. 2008, 21, 218-223. [PubMed]
75. Forbes, J.M.; Cooper, M.E. Mechanisms of diabetic complications. Physiol. Rev. 2013, 93, 137-188. [CrossRef] [PubMed]
76. Larsson, S.C.; Wolk, A. Magnesium intake and risk of type 2 diabetes: A meta-analysis. J. Intern. Med. 2007, 262, 208-214. [CrossRef] [PubMed]
77. Kim, D.J.; Xun, P.; Liu, K.; Loria, C.; Yokota, K.; Jacobs, D.R., Jr.; He, K. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 2010, 33, 2604-2610. [CrossRef] [PubMed]
78. Dong, J.Y.; Xun, P.; He, K.; Qin, L.Q. Magnesium intake and risk of type 2 diabetes: Meta-analysis of prospective cohort studies. Diabetes Care 2011, 34, 2116-2122. [CrossRef] [PubMed]
79. Wang, J.; Persuitte, G.; Olendzki, B.C.; Wedick, N.M.; Zhang, Z.; Merriam, P.A.; Fang, H.; Carmody, J.; Olendzki, G.F.; Ma, Y. Dietary magnesium intake improves insulin resistance among non-diabetic individuals with metabolic syndrome participating in a dietary trial. Nutrients 2013, 5, 3910-3919. [CrossRef] [PubMed]
80. Hruby, A.; Meigs, J.B.; O’Donnell, C.J.; Jacques, P.F.; McKeown, N.M. Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged americans. Diabetes Care 2014, 37, 419-427. [CrossRef] [PubMed]
81. Mooren, F.C.; Krüger, K.; Völker, K.; Golf, S.W.; Wadepuhl, M.; Kraus, A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects-A double-blind, placebo-controlled, randomized trial. Diabetes Obes. Metab. 2011, 13, 281-284. [CrossRef] [PubMed]
82. Von Ehrlich, B.; Wadepuhl, M. Erhöhtes Risiko einer diabetischen Retinopathie bei niedrigem Serum-Magnesium. Diabetes Stoffwechs. 2003, 12, 285-289.
83. De Leeuw, I.; Engelen, W.; de Block, C.; van Gall, L. Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1DM). Mag. Res. 2004, 17, 109-114.
84. Pham, P.C.; Pham, P.M.; Pham, P.T.; Pham, S.V.; Pham, P.A.; Pham, P.T. The link between lower serum magnesium and kidney function in patients with diabetes mellitus type 2 deserves a closer look. Clin. Nephrol. 2009, 71, 375-379. [CrossRef] [PubMed]
85. 2+ in etiology of diabetic complications. Diabetes 1992, 41, 35-39. [CrossRef] [PubMed]
86. Huang, J.H.; Lu, Y.F.; Cheng, F.C.; Lee, J.N.; Tsai, L.C. Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: A cross-sectional study. Nutr. J. 2012, 11, [CrossRef] [PubMed]
87. Guerrero-Romero, F.; Rascón-Pacheco, R.A.; Rodríguez-Morán, M.; de la Peña, J.E.; Wacher, N. Hypomagnesaemia and risk for metabolic glucose disorders: A 10-year follow-up study. Eur. J. Clin. Investig. 2008, 38, 389-396. [CrossRef] [PubMed]
88. Fox, C.; Ramsoomair, D.; Carter, C. Magnesium: Its proven and potential clinical significance. South. Med. J. 2001, 94, 1195-1201. [CrossRef] [PubMed]
89. Kisters, K.; Gremmler, B.; Hausberg, M. Pulse pressure, plasma magnesium status, and antihypertensive therapy. Am. J. Hypertens. 2005, 18, 1136. [CrossRef] [PubMed]
90. Kisters, K.; Tepel, M.; Spieker, C.; Zidek, W.; Barenbrock, M.; Tokmak, F.; Kosch, M.; Hausberg, M.; Rahn, K.H. Decreased membrane Mg2+ concentrations in a subgroup of hypertensives: Membrane model for the pathogenesis of primary hypertension. Am. J. Hypertens. 1998, 11, 1390-1393. [CrossRef]
91. Kosch, M.; Hausberg, M.; Westermann, G.; Köneke, J.; Matzkies, F.; Rahn, K.H.; Kisters, K. Alterations in calcium and magnesium content of red cell membranes in patients with primary hypertension. Am. J. Hypertens. 2001, 14, 254-258. [CrossRef]
92. Kisters, K.; Wessels, F.; Küper, H.; Tokmak, F.; Krefting, E.R.; Gremmler, B.; Kosch, M.; Barenbrock, M.; Hausberg, M. Increased calcium and decreased magnesium concentrations and an increased calcium/magnesium ratio in spontaneously hypertensive rats versus Wistar-Kyoto rats: Relation to arteriosclerosis. Am. J. Hypertens. 2004, 17, 59-62. [CrossRef]
93. Kisters, K.; Wessels, F.; Tokmak, F; Krefting, E.R.; Gremmler, B.; Kosch, M.; Hausberg, M. Early-onset increased calcium and decreased magnesium concentrations and an increased calcium/magnesium ratio in SHR versus WKY. Magnes. Res. 2004, 17, 264-269. [PubMed]
94. Nadler, J.L.; Buchanan, T.; Natarajan, R.; Antonipillai, I.; Bergman, R.; Rude, R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993, 21, 1024-1029. [CrossRef] [PubMed]
95. Euser, A.G.; Cipolla, M.J. Magnesium sulfate for the treatment of eclampsia: A brief review. Stroke 2009, 40, 1169-1175. [CrossRef] [PubMed]
96. Jee, S.H.; Miller, E.R.; Guallar, E.; Singh, V.K.; Appel, L.J.; Klag, M.J. The effect of magnesium supplementation on blood pressure: A meta-analysis of randomized clinical trials. Am. J. Hypertens. 2002, 15, 691-696. [CrossRef]
97. Dickinson, H.O.; Nicolson, D.J.; Campbell, F.; Cook, J.V.; Beyer, F.R.; Ford, G.A.; Mason, J. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst. Rev. 2006. [CrossRef]
98. Kass, L.; Weekes, J.; Carpenter, L. Effect of magnesium supplementation on blood pressure: A meta-analysis. Eur. J. Clin. Nutr. 2012, 66, 411-418. [CrossRef] [PubMed]
99. Hatzistavri, L.S.; Sarafidis, P.A.; Georgianos, P.I.; Tziolas, I.M.; Aroditis, C.P.; Zebekakis, P.E.; Pikilidou, M.I.; Lasaridis, A.N. Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. Am. J. Hypertens. 2009, 22, 1070-1075. [CrossRef] [PubMed]
100. Kisters, K. Oral magnesium supplementation improves borderline hypertension. Magnes. Res. 2011, 24, [PubMed]
101. Kass, L.S.; Skinner, P.; Poeira, F. A pilot study on the effects of magnesium supplementation with high and low habitual dietary magnesium intake on resting and recovery from aerobic and resistance exercise and systolic blood pressure. J. Sports Sci. Med. 2013, 12, 144-150. [PubMed]
102. Peacock, J.M.; Ohira, T.; Post, W.; Sotoodehnia, N.; Rosamond, W.; Folsom, A.R. Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am. Heart. J. 2010, 160, 464-470. [CrossRef] [PubMed]
103. Prevention of REnal and Vascular ENd-stage Disease (PREVEND). Available online: https://www.bioshare.eu/content/prevention-renal-and-vascular-end-stage-disease (accessed on 22 September 2015)
104. Joosten, M.M.; Gansevoort, R.T.; Mukamal, K.J.; van der Harst, P.; Geleijnse, J.M.; Feskens, E.J.; Navis, G.; Bakker, S.J.; PREVEND Study Group. Urinary and plasma magnesium and risk of ischemic heart disease. Am. J. Clin. Nutr. 2013, 97, 1299-1306. [CrossRef] [PubMed]
105. Del Gobbo, L.C.; Imamura, F.; Wu, J.H.; de Oliveira Otto, M.C.; Chiuve, S.E.; Mozaffarian, D. Circulating and dietary magnesium and risk of cardiovascular disease: A systematic review and meta-analysis of prospective studies. Am. J. Clin. Nutr. 2013, 98, 160-173. [CrossRef] [PubMed]
106. Stepura, O.B.; Martynow, A.I. Magnesium orotate in severe congestive heart failure (MACH). Int. J. Cardiol. 2009, 134, 145-147. [CrossRef] [PubMed]
107. Kisters, K.; Gremmler, B.; Gröber, U. Natriuretic peptides, hypertension, heart insufficiency and magnesium. Adv. Tech. Biol. Med. 2015. [CrossRef]
108. Kisters, K.; Gremmler, B.; Gröber, U. Magnesium deficiency in hypertensive heart disease. J Hypertens 2015, 33, e273. [CrossRef]
109. Adebamowo, S.N.; Spiegelman, D.; Willett, W.C.; Rexrode, K.M. Association between intakes of magnesium, potassium, and calcium and risk of stroke: 2 Cohorts of US women and updated meta-analyses. Am. J. Clin. Nutr. 2015, 101, 1269-1277. [CrossRef] [PubMed]
110. Drew, B.J.; Ackerman, M.J.; Funk, M.; Gibler, W.B.; Kligfield, P.; Menon, V.; Philippides, G.J.; Roden, D.M.; Zareba, W.; American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology; the Council on Cardiovascular Nursing; the American College of Cardiology Foundation. Prevention of torsade de pointes in hospital settings: A scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation 2010, 121, 1047-1060. [PubMed]
111. Liu, F.; Zhang, X.; Qi, H.; Wang, J.; Wang, M.; Zhang, Y.; Yan, H.; Zhuang, S. Correlation of serum magnesium with cardiovascular risk factors in maintenance hemodialysis patients-A cross-sectional study. Magnes. Res. 2013, 26, 100-108. [PubMed]
112. Saver, J.L.; Starkman, S.; Eckstein, M.; Stratton, S.J.; Pratt, F.D.; Hamilton, S.; Conwit, R.; Liebeskind, D.S.; Sung, G.; Kramer, I.; et al. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N. Engl. J. Med. 2015, 372, 528-536. [CrossRef] [PubMed]
113. Woods, K.L.; Fletcher, S.; Roffe, C.; Haider, Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: Results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992, 339, 1553-1558. [CrossRef]
114. Fourth International Study of Infarct Survival Collaborative Group. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. The Lancet 1995, 345, 669-682
115. Magnesium in Coronaries (MAGIC) Trial Investigators. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: A randomised controlled trial. Lancet 2002, 360, 1189-1196
116. Altman, D.; Carroli, G.; Duley, L.; Farrell, B.; Moodley, J.; Neilson, J.; Smith, D. Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial. Lancet 2002, 359, 1877-1890. [PubMed]
117. Belfort, M.A.; Anthony, J.; Saade, G.R.; Allen, J.C., Jr.; Nimodipine Study Group. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N. Engl. J. Med. 2003, 348, 304-311. [CrossRef] [PubMed]
118. Mauskop, A.; Altura, B.T.; Cracco, R.Q.; Altura, B.M. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache 1996, 36, 154-160. [CrossRef] [PubMed]
119. Mauskop, A.; Altura, B.T.; Cracco, R.Q.; Altura, B.M. Intravenous magnesium sulfate relieves cluster headaches in patients with low serum ionized magnesium levels. Headache 1995, 35, 597-600. [CrossRef] [PubMed]
120. Peikert, A; Wilimzig, C.; Köhne-Volland, R. Prophylaxis of migraine with oral magnesium: Results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996, 16, 257-263. [CrossRef] [PubMed]
121. The International Headache Society Criteria. Available online: http://ihs-classification.org/de/ (accessed on 22 September 2015)
122. Gaul, C.; Diener, H.C.; Danesch, U.; Migraventr Study Group. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: A randomized, placebo-controlled, double-blind, multicenter trial. J. Headache Pain 2015, 16, [CrossRef] [PubMed]
123. Bigal, M.E.; Bordini, C.A.; Tepper, S.J.; Speciali, J.G. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia 2002, 22, 345-353. [CrossRef] [PubMed]
124. Shahrami, A.; Assarzadegan, F.; Hatamabadi, H.R.; Asgarzadeh, M.; Sarehbandi, B.; Asgarzadeh, S. Comparison of therapeutic effects of magnesium sulfate vs. dexamethasone/metoclopramide on alleviating acute migraine headache. J. Emerg. Med. 2015, 48, 69-76. [CrossRef] [PubMed]
125. Nogovitsina, O.R.; Levitina, E.V. Diagnostic value of examination of the magnesium homeostasis in children with attention deficit syndrome with hyperactivity. Klin. Lab. Diagn. 2005, 5, 17-19. [PubMed]
126. Starobrat-Hermelin, B.; Kozielec, T. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Magnes. Res. 1997, 10, 149-156. [PubMed]
127. Mousain-Bosc, M.; Roche, M.; Rapin, J.; Bali, J.P. Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. J. Am. Coll Nutr. 2004, 23, 545S-548S. [CrossRef] [PubMed]
128. Mousain-Bosc, M.; Roche, M.; Polge, A.; Pradal-Prat, D.; Rapin, J.; Bali, J.P. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. I. Attention deficit hyperactivity disorders. Magnes. Res. 2006, 19, 46-52. [PubMed]
129. Mousain-Bosc, M.; Roche, M.; Polge, A.; Pradal-Prat, D.; Rapin, J.; Bali, J.P. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism. Magnes. Res. 2006, 19, 53-62. [PubMed]
130. Nogovitsina, O.R.; Levitina, E.V. Effect of MAGNE-B6 on the clinical and biochemical manifestations of the syndrome of attention deficit and hyperactivity in children. Eksp. Klin. Farmakol. 2006, 69, 74-77. [PubMed]
131. Bardgett, M.E.; Schultheis, P.J.; McGill, D.L.; Richmond, R.E.; Wagge, J.R. Magnesium deficiency impairs fear conditioning in mice. Brain Res. 2005, 1038, 100-106. [CrossRef] [PubMed]
132. Barbagallo, M.; Belvedere, M.; Di Bella, G.; Dominguez, L.J. Altered ionized magnesium levels in mild-to-moderate Alzheimer’s disease. Magnes. Res. 2011, 24, S115-S121. [PubMed]
133. Cherbuin, N.; Kumar, R.; Sachdev, P.S.; Anstey, K.J. Dietary Mineral Intake and Risk of Mild Cognitive Impairment: The PATH through Life Project. Front. Aging Neurosci. 2014. [CrossRef] [PubMed]
134. Andrási, E.; Igaz, S.; Molnár, Z.; Makó, S. Disturbances of magnesium concentrations in various brain areas in Alzheimer’s disease. Magnes. Res. 2000, 13, 189-196. [PubMed]
135. Li, W.; Yu, J.; Liu, Y.; Huang, X.; Abumaria, N.; Zhu, Y.; Huang, X.; Xiong, W.; Ren, C.; Liu, X.G.; et al. Elevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer’s disease mouse model. J. Neurosci. 2013, 33, 8423-8441. [CrossRef] [PubMed]
136. Xu, Z.P.; Li, L.; Bao, J.; Wang, Z.H.; Zeng, J.; Liu, E.J.; Li, X.G.; Huang, R.X.; Gao, D.; Li, M.Z.; et al. Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer’s model. PLoS ONE 2014, 9, e108645. [CrossRef] [PubMed]
137. Skobeloff, E.M.; Spivey, W.H.; McNamara, R.M.; Greenspon, L. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA 1989, 262, 1210-1213. [CrossRef] [PubMed]
138. Kokotajlo, S.; Degnan, L.; Meyers, R.; Siu, A.; Robinson, C. Use of intravenous magnesium sulfate for the treatment of an acute asthma exacerbation in pediatric patients. J. Pediatr. Pharmacol. Ther. 2014, 19, 91-97. [CrossRef] [PubMed]
139. Cheuk, D.K.; Chau, T.C.; Lee, S.L. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch. Dis. Child. 2005, 90, 74-77. [CrossRef] [PubMed]
140. Blitz, M.; Blitz, S.; Bease, R.; Diner, B.M.; Hughes, R.; Knopp, J.A.; Rowe, B.H. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst. Rev. 2005, 3, CD003898. [PubMed]
141. Tarleton, E.K.; Littenberg, B. Magnesium intake and depression in adults. J. Am. Board Fam. Med. 2015, 28, 249-256. [CrossRef] [PubMed]
142. Benassi, L.; Barletta, F.P.; Baroncini, L.; Bertani, D.; Filippini, F.; Beski, L.; Nani, A.; Tesauri, P.; Tridenti, G. Effectiveness of magnesium pidolate in the prophylactic treatment of primary dysmenorrhea. Clin. Exp. Obstet. Gynecol. 1992, 19, 176-179. [PubMed]
143. Alraek, T.; Lee, M.S.; Choi, T.Y.; Cao, H.; Liu, J. Complementary and alternative medicine for patients with chronic fatigue syndrome: A systematic review. BMC Complement. Altern. Med. 2011. [CrossRef] [PubMed]
144. Bagis, S.; Karabiber, M.; As, I.; Tamer, L.; Erdogan, C.; Atalay, A. Is magnesium citrate treatment effective on pain, clinical parameters and functional status in patients with fibromyalgia? Rheumatol. Int. 2013, 33, 167-172. [CrossRef] [PubMed]
145. Choi, Y.H.; Miller, J.M.; Tucker, K.L.; Hu, H.; Park, S.K. Antioxidant vitamins and magnesium and the risk of hearing loss in the US general population. Am. J. Clin. Nutr. 2014, 99, 148-155. [CrossRef] [PubMed]
146. Riley, J.M.; Kim, H.; Averch, T.D.; Kim, H.J. Effect of magnesium on calcium and oxalate ion binding. J. Endourol. 2013, 27, 1487-1492. [CrossRef] [PubMed]
147. Ebrahimi, E.; Khayati Motlagh, S.; Nemati, S.; Tavakoli, Z. Effects of magnesium and vitamin B6 on the severity of premenstrual syndrome symptoms. J. Caring Sci. 2012, 1, 183-189. [PubMed]
148. Cevette, M.J.; Barrs, D.M.; Patel, A.; Conroy, K.P.; Sydlowski, S.; Noble, B.N.; Nelson, G.A.; Stepanek, J. Phase 2 study examining magnesium-dependent tinnitus. Int. Tinnitus J. 2011, 16, 168-173. [PubMed]
149. Kisters, K. What is the correct magnesium supplement? Magnes. Res. 2013, 26, 41-42. [PubMed]